Carnosic Acid Reverses the Inhibition of ApoE4 on Cell Surface Level of ApoER2 and Reelin Signaling Pathway
- PMID: 31796678
- DOI: 10.3233/JAD-190914
Carnosic Acid Reverses the Inhibition of ApoE4 on Cell Surface Level of ApoER2 and Reelin Signaling Pathway
Abstract
The cell surface level of apolipoprotein E receptor 2 (ApoER2) increases by cyclic transport of ApoER2 and then activates Reelin signaling pathway to exert neuroprotective function in AD. ApoER2 ligand Apolipoprotein E4 (ApoE4) inhibits the recycling of ApoER2 to the cell surface rendering neurons unresponsive to Reelin. Carnosic acid (CA) is proven to possess neuroprotective and neurotrophic functions in Alzheimer's disease (AD) mouse model. However, there are few reports about how ApoE4 impairs the recycling of ApoER2 and if CA can affect the cyclic transport of ApoER2. In this study, we demonstrated that ApoE4 attenuates the binding of sorting nexin 17 (SNX17) to ApoER2 and inhibits the recycling of ApoER2, resulting in decreased cell surface level of ApoER2. Further, we found that CA enhances the binding of SNX17 to ApoER2, counteracts the negative effects of ApoE4 on the cell surface level of ApoER2 to reverse the ApoE4-induced reduction in Reelin signaling activation by increasing the phosphorylation of the N-methyl-D-aspartate receptor (NMDAR) and cAMP-response element-binding protein (CREB) and the expression of Gria2. Thus, CA promotes neurite growth inhibited by ApoE4. Our work suggests that CA may be a potential approach to attenuate the risk of ApoE4-associated AD.
Keywords: Apolipoprotein E receptor 2; Apolipoprotein E4; Reelin signaling pathway; carnosic acid; sorting nexin 17.
Similar articles
-
Sorting nexin 17 regulates ApoER2 recycling and reelin signaling.PLoS One. 2014 Apr 4;9(4):e93672. doi: 10.1371/journal.pone.0093672. eCollection 2014. PLoS One. 2014. PMID: 24705369 Free PMC article.
-
ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling.Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):12011-6. doi: 10.1073/pnas.0914984107. Epub 2010 Jun 14. Proc Natl Acad Sci U S A. 2010. PMID: 20547867 Free PMC article.
-
Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease.FASEB J. 2018 Jul;32(7):3536-3546. doi: 10.1096/fj.201700736RR. Epub 2018 Feb 9. FASEB J. 2018. PMID: 29442527
-
Reelin links Apolipoprotein E4, Tau, and Amyloid-β in Alzheimer's disease.Ageing Res Rev. 2024 Jul;98:102339. doi: 10.1016/j.arr.2024.102339. Epub 2024 May 14. Ageing Res Rev. 2024. PMID: 38754634 Review.
-
The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor.Int J Mol Sci. 2018 Oct 9;19(10):3090. doi: 10.3390/ijms19103090. Int J Mol Sci. 2018. PMID: 30304853 Free PMC article. Review.
Cited by
-
OCRL1 Deficiency Affects the Intracellular Traffic of ApoER2 and Impairs Reelin-Induced Responses.Biomolecules. 2024 Jul 5;14(7):799. doi: 10.3390/biom14070799. Biomolecules. 2024. PMID: 39062513 Free PMC article.
-
Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action.Molecules. 2023 Mar 2;28(5):2306. doi: 10.3390/molecules28052306. Molecules. 2023. PMID: 36903551 Free PMC article. Review.
-
Sorting nexin 17 increases low-density lipoprotein receptor-related protein 4 membrane expression: A novel mechanism of acetylcholine receptor aggregation in myasthenia gravis.Front Immunol. 2022 Oct 12;13:916098. doi: 10.3389/fimmu.2022.916098. eCollection 2022. Front Immunol. 2022. PMID: 36311763 Free PMC article.
-
Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases.Int J Mol Sci. 2022 Aug 31;23(17):9892. doi: 10.3390/ijms23179892. Int J Mol Sci. 2022. PMID: 36077289 Free PMC article. Review.
-
The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.J Alzheimers Dis. 2024;97(2):753-775. doi: 10.3233/JAD-230514. J Alzheimers Dis. 2024. PMID: 38217595 Free PMC article.